An OpenData portal to share COVID-19 drug repurposing data in real time
Brimacombe, K. R.; Zhao, T.; Eastman, R. T.; Hu, X.; Wang, K.; Backus, M.; Baljinnyam, B.; Chen, C. Z.; Chen, L.; Eicher, T.; Ferrer, M.; Fu, Y.; Gorshkov, K.; Guo, H.; Hanson, Q. M.; Itkin, Z.; Kales, S. C.; Klumpp-Thomas, C.; Lee, E. M.; Michael, S.; Mierzwa, T.; Patt, A.; Pradhan, M.; Renn, A.; Shinn, P.; Shrimp, J. H.; Viraktamath, A.; Wilson, K. M.; Xu, M.; Zakharov, A. V.; Zhu, W.; Zheng, W.; Simeonov, A.; Mathe, E. A.; Lo, D. C.; Hall, M. D.; Shen, M.
Show abstract
The National Center for Advancing Translational Sciences (NCATS) has developed an online open science data portal for its COVID-19 drug repurposing campaign - named OpenData - with the goal of making data across a range of SARS-CoV-2 related assays available in real-time. The assays developed cover a wide spectrum of the SARS-CoV-2 life cycle, including both viral and human (host) targets. In total, over 10,000 compounds are being tested in full concentration-response ranges from across multiple annotated small molecule libraries, including approved drug, repurposing candidates and experimental therapeutics designed to modulate a wide range of cellular targets. The goal is to support research scientists, clinical investigators and public health officials through open data sharing and analysis tools to expedite the development of SARS-CoV-2 interventions, and to prioritize promising compounds and repurposed drugs for further development in treating COVID-19.
Matching journals
The top 12 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Oral drug repositioning candidates and synergistic remdesivir combinations for the prophylaxis and treatment of COVID-19 94%
- First fully-automated AI/ML virtual screening cascade implemented at a drug discovery centre in Africa 94%
- A novel preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs 93%
Similar papers in this journal
- CROssBAR: Comprehensive Resource of Biomedical Relations with Deep Learning Applications and Knowledge Graph Representations 93%
- PharmacoDB 2.0 : Improving scalability and transparency of in vitro pharmacogenomics analysis 92%
- DrugComb update: a more comprehensive drug sensitivity data repository and analysis portal 92%
Similar papers in this journal
- Repurposing Therapeutics for COVID-19: Rapid Prediction of Commercially available drugs through Machine Learning and Docking 94%
- A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV-2 main protease. 93%
- TargetDB: A target information aggregation tool and tractability predictor 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.